Jeeun Kang

Flexible and elastic metamaterial absorber for low frequency, based on small-size unit cell

Using a planar and flexible metamaterial (MM), we obtained the low-frequency perfect absorption even with very small unit-cell size in snake-shape structure. These shrunken, deep-sub-wavelength and thin MM absorbers were numerically and experimentally investigated by increasing the inductance. The periodicity/thickness (the figure of merit for perfect absorption) is achieved to be 10 and 2 for single-snake-bar and 5-snake-bar structures, respectively. The ratio between periodicity and resonance wavelength (in mm) is close to 1/12 and 1/30 at 2 GHz and 400 MHz, respectively. The absorbers are specially designed for absorption peaks around 2 GHz and 400 MHz, which can be used for depressing the electromagnetic noise from everyday electronic devices and mobile phones.

A single FPGA-based portable ultrasound imaging system for point-of-care applications

We present a cost-effective portable ultrasound system based on a single field-programmable gate array (FPGA) for point-of-care applications. In the portable ultrasound system developed, all the ultrasound signal and image processing modules, including an effective 32-channel receive beamformer with pseudo-dynamic focusing, are embedded in an FPGA chip. For overall system control, a mobile processor running Linux at 667 MHz is used. The scan-converted ultrasound image data from the FPGA are directly transferred to the system controller via external direct memory access without a video processing unit. The potable ultrasound system developed can provide real-time B-mode imaging with a maximum frame rate of 30, and it has a battery life of approximately 1.5 h. These results indicate that the single FPGA-based portable ultrasound system developed is able to meet the processing requirements in medical ultrasound imaging while providing improved flexibility for adapting to emerging POC applications.

Enhancement of photoacoustic image quality by sound speed correction: ex vivo evaluation

Real-time photoacoustic (PA) imaging involves beamforming methods using an assumed fixed sound speed, typically 1540 m/s in soft tissue. This leads to degradation of PA image quality because the true sound speed changes as PA signal propagates through different types of soft tissues: the range from 1450 m/s to 1600 m/s. This paper proposes a new method for estimating an optimal sound speed to enhance the cross-sectional PA image quality. The optimal sound speed is determined when coherent factor with the sound speed is maximized. The proposed method was validated through simulation and ex vivo experiments with microcalcification-contained breast cancer specimen. The experimental results demonstrated that the best lateral resolution of PA images of microcalcifications can be achieved when the optimal sound speed is utilized.

Optimal laser wavelength for photoacoustic imaging of breast microcalcifications

This paper presents photoacoustic imaging (PAI) for real-time detection of micro-scale calcifications (e.g., <1 mm) in the breast, which are an indicator of the cancer occurrence. Optimal wavelength of incident laser for the microcalcification imaging was ascertained through ex vivo experiments with seven breast specimens of volunteers. In the ex vivo experiments, the maximum amplitude of photoacoustic signals from the microcalcifications occurred when the laser wavelength ranged from 690 to 700 nm. This result demonstrated that PAI can serve as a real-time imaging and guidance tool for diagnosis and biopsy of the breast microcalcifications.

Photoacoustic imaging of breast microcalcifications: A validation study with 3-dimensional ex vivo data and spectrophotometric measurement

Breast microcalcification has been served as an important early-indicator of breast cancer. In the conventional screening procedure for the breast cancer, X-ray mammography is first conducted and the malignancy of the suspicious patient is confirmed by conducting needle biopsy with real-time imaging-assisted guidance, i.e., stereotactic and US imaging. However, these biopsy guidance methods suffer from large amount of radiative exposure and limited sensitivity on microcalcifications without a mass, respectively. In this paper, we verify the capability of photoacoustic imaging (PAI) for detection of the breast microcalcifications by comparing their locations in a 3-D PA image with those in the corresponding X-ray mammography. For this, cross-sectional PA/US images of breast ex vivo specimens were sequentially acquired with 7.2-MHz linear array transducer and the procedure was repeated by moving the transducer along the elevation direction at an increment of 0.3 mm. A Surelite Nd:YAG OPO system (Continuum Inc., USA) was used for the laser excitation at the rate of 10 Hz with a bifurcated optical fiber bundle for laser delivery. PA signals generated in the specimen were captured with SonixTouch research package (Ultrasonix Corp., Canada). With a volume-rendered PA/US image, it is shown that the locations of the microcalcifications in the X-ray mammography meshed well with those in PA images. From the experimental results, therefore, it is demonstrates that PAI can be an effective alternative for noninvasive, real-time biopsy guidance for breast cancer screening.

Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.

Biomedical imaging-guided cancer therapy should have capabilities of both accurate tumor diagnosis and high therapeutic efficacy for the personalized treatment. Various biomedical imaging-guided cancer therapies are currently being investigated to overcome current limitations that include low sensitivity of diagnosis and poor drug delivery to the tumor site. Here, we report the development of a multifunctional theranostic contrast agent demonstrating high sensitive photoacoustic and ultrasound imaging and effective local delivery of anticancer drug to a tumor site. A microbubble (porphyrin-MB) was developed using phospholipid-porphyrin conjugates to enhance ultrasound and photoacoustic signal intensities simultaneously. Paclitaxel-loaded human serum albumin nanoparticles (PTX-HSA-NPs) were then conjugated onto the surface of the microbubble. The developed PTX-HSA-NPs conjugated porphyrin-MB (porphyrin-MB-NPs) provided sensitive, dual modal images of a tumor at 700 nm optimal laser wavelength for photoacoustic imaging and 5-14 MHz operating frequency for the ultrasound imaging. In addition, porphyrin-MB-NPs efficiently suppressed tumor growth by ultrasound exposure. Exposure to the focused ultrasound triggered the collapse of porphyrin-MB-NPs, resulting in the local release of PTX-HSA-NPs and enhanced penetration into the tumor site. The increased preferential accumulation and penetration of PTX-HSA-NPs suppressed tumor growth 10-fold more than without exposure to ultrasound. In conclusion, the developed porphyrin-MB-NPs establish a new paradigm in simultaneous bi-functional ultrasound/photoacoustic imaging diagnosis and locally triggered release of nanomedicine and enhanced chemotherapy efficiency.

A System-on-Chip Solution for Point-of-Care Ultrasound Imaging Systems: Architecture and ASIC Implementation

In this paper, we present a novel system-on-chip (SOC) solution for a portable ultrasound imaging system (PUS) for point-of-care applications. The PUS-SOC includes all of the signal processing modules (i.e., the transmit and dynamic receive beamformer modules, mid- and back-end processors, and color Doppler processors) as well as an efficient architecture for hardware-based imaging methods (e.g., dynamic delay calculation, multi-beamforming, and coded excitation and compression). The PUS-SOC was fabricated using a UMC 130-nm NAND process and has 16.8 GFLOPS of computing power with a total equivalent gate count of 12.1 million, which is comparable to a Pentium-4 CPU. The size and power consumption of the PUS-SOC are 27×27 mm2 and 1.2 W, respectively. Based on the PUS-SOC, a prototype hand-held US imaging system was implemented. Phantom experiments demonstrated that the PUS-SOC can provide appropriate image quality for point-of-care applications with a compact PDA size ( 200×120×45 mm3) and 3 hours of battery life.

Smartphone-based portable ultrasound imaging system: Prototype implementation and evaluation

In this paper, we present a smart US imaging system (SMUS) based on an android-OS smartphone, which can provide maximally optimized efficacy in terms of weight and size in point-of-care diagnostic applications. The proposed SMUS consists of the smartphone (Galaxy S5 LTE-A, Samsung., Korea) and a 16-channel probe system. The probe system contains analog and digital front-ends, which conducts beamforming and mid-processing procedures. Otherwise, the smartphone performs the back-end processing including envelope detection, log compression, 2D image filtering, digital scan conversion, and image display with custom-made graphical user interface (GUI). Note that the probe system and smartphone are interconnected by the USB 3.0 protocol. As a result, the developed SMUS can provide real-time B-mode image with the sufficient frame rate (i.e., 58 fps), battery run-time for point-of-care diagnosis (i.e., 54 min), and 35.0°C of transducer surface temperature during B-mode imaging, which satisfies the temperature standards for the safety and effectiveness of medical electrical equipment, IEC 60601-1 (i.e., 43°C).

Photoacoustic Imaging of Breast Microcalcifications: A Preliminary Study with 8-Gauge Core-Biopsied Breast Specimens

Background We presented the photoacoustic imaging (PAI) tool and to evaluate whether microcalcifications in breast tissue can be detected on photoacoustic (PA) images. Methods We collected 21 cores containing microcalcifications (n = 11, microcalcification group) and none (n = 10, control group) in stereotactic or ultrasound (US) guided 8-gauge vacuum-assisted biopsies. Photoacoustic (PA) images were acquired through ex vivo experiments by transmitting laser pulses with two different wavelengths (700 nm and 800 nm). The presence of microcalcifications in PA images were blindly assessed by two radiologists and compared with specimen mammography. A ratio of the signal amplitude occurring at 700 nm to that occurring at 800 nm was calculated for each PA focus and was called the PAI ratio. Results Based on the change of PA signal amplitude between 700 nm and 800 nm, 10 out of 11 specimens containing microcalcifications and 8 out of 10 specimens without calcifications were correctly identified on blind review; the sensitivity, specificity, accuracy, positive predictive and negative predictive values of our blind review were 90.91%, 80.0%, 85.71%, 83.33% and 88.89%. The PAI ratio in the microcalcification group was significantly higher than that in the control group (the median PAI ratio, 2.46 versus 1.11, respectively, P = .001). On subgroup analysis in the microcalcification group, neither malignant diagnosis nor the number or size of calcification-foci was proven to contribute to PAI ratios. Conclusion Breast microcalcifications generated distinguishable PA signals unlike breast tissue without calcifications. So, PAI, a non-ionizing and non-invasive hybrid imaging technique, can be an alternative in overcoming the limitations of conventional US imaging.

A prototype hand-held tri-modal instrument for in vivo ultrasound, photoacoustic, and fluorescence imaging

Multi-modality imaging is beneficial for both preclinical and clinical applications as it enables complementary information from each modality to be obtained in a single procedure. In this paper, we report the design, fabrication, and testing of a novel tri-modal in vivo imaging system to exploit molecular/functional information from fluorescence (FL) and photoacoustic (PA) imaging as well as anatomical information from ultrasound (US) imaging. The same ultrasound transducer was used for both US and PA imaging, bringing the pulsed laser light into a compact probe by fiberoptic bundles. The FL subsystem is independent of the acoustic components but the front end that delivers and collects the light is physically integrated into the same probe. The tri-modal imaging system was implemented to provide each modality image in real time as well as co-registration of the images. The performance of the system was evaluated through phantom and in vivo animal experiments. The results demonstrate that combining the modalities does not significantly compromise the performance of each of the separate US, PA, and FL imaging techniques, while enabling multi-modality registration. The potential applications of this novel approach to multi-modality imaging range from preclinical research to clinical diagnosis, especially in detection/localization and surgical guidance of accessible solid tumors.